Las pharmaceutical that market their medicines in New York will not be able to continue raising the costs of their products without any control, because from now on the manufacturers of certain prescription medicines will have a brake, since they must notify the Department of Financial Services about any proposal to increase prices that they intend to make.
This is what the call warns drug price transparency lawapproved last June by the Legislature, and enacted this week by Governor Kathy Hochulwho after months of pressure, finally signed his signature on the new rule, which will order pharmaceutical companies to intend to make increases above 16% in medicines, that explain and publicly support why prices are rising.
The law Not only will it bring prescription drug manufacturers to task, but it even aims to reduce the price of medications and make the administration of these products safer, putting an end to indiscriminate increases.
“Too many New Yorkers are struggling with the high cost of prescription drugs, and I am committed to doing everything in my power to help, and this legislation will increase transparency and safety for all New Yorkers,” she said. the state representative.
With the entry into force of the new law, New York joins 19 other states that have enacted transparency laws on the increase in the costs of medicines, which have contributed to the reduction in costs, as happened in Vermont, the first state to implement such regulations, and achieved a reduction of almost 80% in medicines with price increases of 15%, between 2016 and 2020.
Governor Hochul also signed another bill into law that seeks to make drug administration by pharmaceutical companies safer and more accessible to patients by authorizing additional medications for the treatment of mental health conditions and substance use disorders, and requires greater communication between the pharmacist and the doctor who prescribes the prescription.
“Allowing patients to receive their long-acting injectable medications for mental health and/or substance use conditions at their local pharmacy with patient consent, is a significant effort to reduce barriers for patients seeking to live their lives.” and manage their illness,” he said. Assemblyman John T. McDonald III. “Through Governor Hochul’s signing of this legislation, New York State is ensuring that patients have greater access to medications and care, and this is critical in underserved areas, such as urban and rural areas, which are “They are becoming healthcare deserts.”
2023-12-28 11:00:00
#Law #enacted #stop #pharmaceutical #companies #seeking #increase #drug #prices #Diario
